Pharmaceutical packaging and labeling is designed to serve 2 main purposes: protection and communication. It exists to protect the medication from outside influences that could cause contamination, for example, but it is also there to protect the patient and/or dispensing healthcare professional from harm. Additionally, the packaging needs to communicate to both the dispensing healthcare professional AND the patient, including detailed information that must be accurate, simple to understand and not open to misinterpretation. This information, along with the specifications of the packaging itself, comes from multiple sources and involves many touch points throughout the supply chain, both externally and internally.
In addition, pharmaceutical and life science companies are under mounting pressure to comply with ever-changing regulations and increasing market pressures whilst maintaining a commercially viable and robust portfolio. Add to that internal organizational expectations, competition from other manufacturers and niche markets and product expansion, and it’s not hard to understand how complexity can creep in to the packaging and labeling portfolio. This complexity can come in many forms such as a greater number of assets per product and SKU, interaction with multiple suppliers throughout the supply chain and managing constant changes in regulations.
Companies need to not only be aware of this challenge but more importantly, they need to ensure that they have controls in place to manage these issues, limiting further complexities arising AND reducing the potential consequences in the future.
In this webinar, the presenter will show how pharmaceutical packaging and labeling complexity occurs, what the consequences are of inaction, and most importantly, what pharmaceutical companies can do to reduce and manage the process.